Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SR-33557' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 21 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sunol, JJ; Saurina, J; Clavaguera, N; Clavaguera-Mora, MT
      Glass transition study of eutectic mixtures for pharmaceutical applications

      JOURNAL OF NON-CRYSTALLINE SOLIDS
    2. Bellissant, E; Giudicelli, JF
      Pharmacokinetic-pharmacodynamic model for fantofarone cardiac and brachialhaemodynamic effects in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    3. GLASSER SP; SINGH SN; HUMEN DP
      SAFETY AND EFFICACY OF MONOTHERAPY WITH FANTOFARONE, A NOVEL CALCIUM-CHANNEL ANTAGONIST, IN PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS

      Journal of clinical pharmacology
    4. LHERITIER J; CHAUVET A; ABRAMOVICI B; MASSE J
      IMPROVEMENT OF THE DISSOLUTION KINETICS OF SR-33557 BY MEANS OF SOLIDDISPERSIONS CONTAINING PEG-6000

      International journal of pharmaceutics
    5. RUTLEDGE A; TRIGGLE DJ
      THE BINDING INTERACTIONS OF RO-40-5967 AT THE L-TYPE CA2+ CHANNEL IN CARDIAC TISSUE

      European journal of pharmacology
    6. YASUI K; PALADE P
      INHIBITORY-ACTION OF SR33557 ON L-TYPE CALCIUM CURRENT IN SINGLE VENTRICULAR MYOCYTES OF RAT

      British Journal of Pharmacology
    7. SPEDDING M; KENNY B; CHATELAIN P
      NEW DRUG-BINDING SITES IN CA2+ CHANNELS

      Trends in pharmacological sciences
    8. CHATELAIN P; DEWINKELEER P; BEAUFORT P; MEYSMANS L; CLINET M
      CHARACTERIZATION OF THE BINDING OF [H-3] SR-33805 TO THE SLOW CA2-HEART SARCOLEMMAL MEMBRANE( CHANNEL IN RAT)

      European journal of pharmacology. Molecular pharmacology section
    9. POINTEAU P; BERGER Y
      SYNTHESIS OF [2-C-14] FANTOFARONE OR 1-[4-[3-N-METHYL N-[3,4-DIMETHYLBETA-PHENETHYL] AMINO PROPYLOXY] BENZENE SULFONYL] 2-ISOPROPYL [2-C-14] INDOLIZINE

      Journal of labelled compounds & radiopharmaceuticals
    10. POTY C; GIBON V; EVRARD G; NORBERG B; VERCAUTEREN DP; GUBIN J; CHATELAIN P; DURANT F
      1-[[4-(AMINOALKOXY)PHENYL]SULFONYL]INDOLIZINES - A NOVEL CLASS OF CALCIUM-ENTRY BLOCKERS - RELATIONSHIPS BETWEEN CHEMICAL-STRUCTURE, STEREOELECTRONIC PROPERTIES AND ANTICALCIC ACTIVITY

      European journal of medicinal chemistry
    11. SAAL JP; LELLOUCHE D; HABBAL R; SISSMANN J; CASTAIGNE A; DUBOISRANDE JL
      HEMODYNAMIC-EFFECTS OF A NEW CALCIUM-ANTAGONIST, SR-33557, IN PATIENTS WITH CORONARY-ARTERY DISEASE AND NORMAL LEFT-VENTRICULAR FUNCTION

      Journal of cardiovascular pharmacology
    12. GIBON V; POTY C; EVRARD G; VERCAUTEREN DP; DURANT F
      MOLECULAR-STRUCTURE AND ELECTRONIC-PROPERTIES OF A 1-SULFONYLINDOLIZINE DERIVATIVE, 2-ISOPROPYL-1-METHYLSULFONYLINDOLIZINE

      Acta crystallographica. Section C, Crystal structure communications
    13. HODEIGE D; CHATELAIN P; MANNING A
      FANTOFARONE (SR-33557) - EFFECTS ON MYOCARDIAL OXYGEN-CONSUMPTION ANDCORONARY BLOOD-FLOW

      Pharmacology
    14. ROMEY G; LAZDUNSKI M
      EFFECTS OF A NEW CLASS OF CALCIUM-ANTAGONISTS, SR33557 (FANTOFARONE) AND SR33805, ON NEURONAL VOLTAGE-ACTIVATED CA++ CHANNELS

      The Journal of pharmacology and experimental therapeutics
    15. CHATELAIN P; MATTEAZZI JR; LARUEL R
      BINDING OF FANTOFARONE, A NOVEL CA2-ALBUMIN - A FLUORESCENCE STUDY( ANTAGONIST, TO SERUM)

      Journal of pharmaceutical sciences
    16. ROMEY G; BOIS P; LAZDUNSKI M
      EFFECTS OF 2 CHEMICALLY RELATED NEW CA2-TYPE CARDIAC CHANNEL( CHANNELANTAGONISTS, SR33557 (FANTOFARONE) AND SR33805, ON THE L)

      European journal of pharmacology
    17. VANDERELST L; CHATELAIN P; MANNING AS; LARUEL R; VANHAVERBEKE Y; MULLER RN
      P-31 NUCLEAR-MAGNETIC-RESONANCE STUDY OF THE EFFECTS OF THE CALCIUM-ION CHANNEL ANTAGONIST FANTOFARONE ON THE RAT-HEART

      European journal of pharmacology
    18. CHATELAIN P; MATTEAZZI JR; LARUEL R
      INTERACTION OF THE CALCIUM-ANTAGONIST FANTOFARONE WITH PHOSPHOLIPIDS - ELECTROSTATIC EFFECTS

      Biochemical pharmacology
    19. CHATELAIN P; CLINET M; POLSTER P; CHRISTOPHE B; MANNING AS
      IN-VITRO CHARACTERIZATION OF A NOVEL CA-2- SR33805( ENTRY BLOCKER )

      European journal of pharmacology. Molecular pharmacology section
    20. GUBIN J; DEVOGELAER H; INION H; HOUBEN C; LUCCHETTI J; MAHAUX J; ROSSEELS G; PEIREN M; CLINET M; POLSTER P; CHATELAIN P
      NOVEL HETEROCYCLIC-ANALOGS OF THE NEW POTENT CLASS OF CALCIUM ENTRY BLOCKERS - 1-[[4-(AMINOALKOXY)PHENYL]SULFONYL]INDOLIZINES

      Journal of medicinal chemistry
    21. GUBIN J; LUCCHETTI J; MAHAUX J; NISATO D; ROSSEELS G; CLINET M; POLSTER P; CHATELAIN P
      A NOVEL CLASS OF CALCIUM-ENTRY BLOCKERS - THE 1-[[4-(AMINOALKOXY)PHENYL]SULFONYL]INDOLIZINES

      Journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 15:32:36